Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

Vaccine

Volumn 27, Issue 18, 2009, Pages 2418-2425

  McElhaney, Janet E ^a,b   Ewen, Catherine ^c   Zhou, Xin ^a   Kane, Kevin P ^c   Xie, Dongxu ^a   Hager, W David ^a   Barry, Mary Beth ^a   Kleppinger, Alison ^a   Wang, Yazhen ^d   Bleackley, R Chris ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Antibody; Granzyme B; Influenza vaccination

Indexed keywords

GRANZYME B; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CELLS, CULTURED; FEMALE; GRANZYMES; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 62749155684     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.136     Document Type: Article

References (31)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 292 11 (2004) 1333-1340
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 2 (2003) 179-186
3. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25 4 (2007) 599-604
4. McMichael A.J., Gotch F.M., Noble G.R., and Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 309 1 (1983) 13-17
5. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., and McMichael A.J. Rapid effector function in CD8+ memory T cells. J Exp Med 186 6 (1997) 859-865
6. Lord S.J., Rajotte R.V., Korbutt G.S., and Bleackley R.C. Granzyme B: a natural born killer. Immunol Rev 193 (2003) 31-38
7. Doherty P.C., Topham D.J., Tripp R.A., Cardin R.D., Brooks J.W., and Stevenson P.G. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159 (1997) 105-117
8. Ewen C., Kane K.P., Shostak I., Griebel P.J., Bertram E.M., Watts T.H., et al. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J Immunol Methods 276 1-2 (2003) 89-101
9. Johnson B.J., Costelloe E.O., Fitzpatrick D.R., Haanen J.B., Schumacher T.N., Brown L.E., et al. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci USA 100 5 (2003) 2657-2662
10. Lawrence C.W., Ream R.M., and Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 174 9 (2005) 5332-5340
11. McElhaney J.E., Gravenstein S., Upshaw C.M., Hooton J.W., Krause P., Drinka P., et al. Granzyme B: a marker of risk for influenza in institutionalized older adults. Vaccine 19 27 (2001) 3744-3751
12. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176 10 (2006) 6333-6339
13. WHO Collaborating Center for Influenza BPD. The hemagglutination inhibition test for influenza viruses (1981), DHEW, PHS, CDC, Center for Infectious Disease, Atlanta, GA p. 1-21 [revised]
14. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 1-2 (2003) 65-78
15. Barry M., and Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2 6 (2002) 401-409
16. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., et al. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J Immunol 172 May (10) (2004) 6407-6417
17. Powers D.C., and Belshe R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 167 3 (1993) 584-592
18. He X.S., Holmes T.H., Mahmood K., Kemble G.W., Dekker C.L., Arvin A.M., et al. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines. J Infect Dis 197 6 (2008) 803-811
19. Terajima M., Cruz J., Leporati A.M., Orphin L., Babon J.A., Co M.D., et al. Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients. J Virol 82 18 (2008) 9283-9287
20. Co M.D., Orphin L., Cruz J., Pazoles P., Rothman A.L., Ennis F.A., et al. Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine 26 16 (2008) 1990-1998
21. McElhaney J.E., Pinkoski M.J., Upshaw C.M., and Bleackley R.C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J Immunol Methods 190 1 (1996) 11-20
22. He X.S., Draghi M., Mahmood K., Holmes T.H., Kemble G.W., Dekker C.L., et al. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 114 12 (2004) 1812-1819
23. de Bree G.J., Heidema J., van Leeuwen E.M., van Bleek G.M., Jonkers R.E., Jansen H.M., et al. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 191 10 (2005) 1710-1718
24. Takata H., and Takiguchi M. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 177 October (7) (2006) 4330-4340
25. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 21 (1994) 1661-1665
26. Nichol K.L. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 16 (2003) 1769-1775
27. Gravenstein S., Drinka P., Duthie E.H., Miller B.A., Brown C.S., Hensley M., et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 42 3 (1994) 245-251
28. Govaert T.M., Sprenger M.J., Dinant G.J., Aretz K., Masurel N., and Knottnerus J.A. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 12 13 (1994) 1185-1189
29. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., and Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75 24 (2001) 12182-12187
30. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168 11 (2002) 5893-5899
31. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 37 2-3 (2002) 427-439